Metraipolis › archive › dc_4bdb79afadbf
Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP) — Europe PMC PMID:41788313
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41788313
- DOI
- 10.1155/crpu/6616379
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T04:17:40.982Z
- SHA-256 of the archived text
7f0fdeaac399f8caca5f4f74665ae649a529257b1e9b7f7cae29a4bfc3b04e56- Stable URL of this page
https://metraipolis.com/documento/dc_4bdb79afadbf
How to cite
Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP) — Europe PMC PMID:41788313 — Europe PMC (en), https://europepmc.org/article/MED/41788313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bdb79afadbf (Metraipolis archive dc_4bdb79afadbf, sha256 7f0fdeaac399f8caca5f4f74665ae649a529257b1e9b7f7cae29a4bfc3b04e56)
BibTeX
@misc{dc4bdb79afadbf,
title = {Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP) — Europe PMC PMID:41788313},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41788313},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bdb79afadbf; sha256 7f0fdeaac399f8caca5f4f74665ae649a529257b1e9b7f7cae29a4bfc3b04e56},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41788313. Agents can read the archived copy with the MCP tool read_document.